Home・Stock List・Medpace Holdings Inc

Medpace Holdings Inc

Closed

SectorHealthcare

574.64 -0.78

Buy Sell

Overview

Share price change

24h

Current

Min

564.94

Max

577.95

Key metrics
By Trading Economics
Income	-2.5M 121M
Sales	727K 707M
P/E Sector Avg	35.334 64.641
EPS	4.25
Profit margin	17.158
Employees	6,500
EBITDA	-21M 134M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+0.54% upside

Dividends
By Acuity
Next Earnings	21 Oct 2026

Market Stats
By TradingEconomics
Market Cap	1.4B 16B
Previous open	575.42
Previous close	574.64

News Sentiment

By Acuity

11%

89%

10 / 340 Healthcare

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

30 Jul 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

29 Jul 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 Jul 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 Jul 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 Jul 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 Jul 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 Jul 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

0.54% upside

12 Months Forecast

Average 580.2 USD 0.54%

High 692 USD

Low 450 USD

Based on 11 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Medpace Holdings Inc - Dist in the past 3 months.

Sentiment

By Acuity

10 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.